Particle sizing and biokinetics of interstitiallymphoscintigraphic agents*

https://doi.org/10.1016/S0001-2998(83)80031-2Get rights and content

The biokinetics of inert lymphoscintigraphic agentsstrongly depends on their particle size. Different techniques for characterization of colloids are discussed. Experiments have been performed on eight different colloids. The particle size has been investigated with scanning electron microscopy. Activity distributions have been obtained with ultrafiltration and gel-column scanning technique. The colloids suggested for lymphoscintigraphy were found to have a median size of about 40–50 nm except one minimicro-aggregated human serum albumin colloid which has a median particle size around 10 nm. The biokinetics were studied with a scintillation camera in rabbits after a subcutaneous injection. Timeactivity curves were generated. After 5 hr the rabbits were dissected and the activity content in different tissues measured. A compartment model for the biokinetics was designed and rate constants evaluated. The total and specific activity uptake in parasternal lymph nodes was highest for the small-particle colloids. The compartment model showed a good fitting to the experimental data.

References (41)

  • YoffeyJM et al.
  • GangonWF
  • AspegrenK et al.

    Quantitative lymphoscintigraphy for detection of metastases to the internal mammary lymph nodes. Biokinetics of 99mTc-sulphur colloid uptake and correlation with microscopy

    Acta Radiologica Oncology

    (1977)
  • StrandSE et al.

    Quantitative lymphoscintigraphy I: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits

    J Nucl Med

    (1979)
  • EgeGN et al.

    Lymphoscintigraphy: a comparison of 99m-Tc-antimony sulphide colloid and 99m-Tc-stannous phytate

    Br J Radiol

    (1979)
  • KaplanWD et al.

    A comparison of two technetium-99m labeled radiopharmaceuticals for lymphoscintigraphy

    J Nucl Med

    (1979)
  • NagaiK et al.

    Experimental studies on uptake of 99mTc antimony sulfide colloid in RES. A comparison with various 99mTc-colloids

    Int J Nucl Med Biol

    (1980)
  • NagaiK et al.

    Deposition of small 99mTc labelled colloids in bone marrow and lymph nodes

    Eur J Nucl Med

    (1982)
  • FrierM

    Phagocytosis

  • WilkinsDJ et al.

    Studies on the relationship between electrophoretic properties of colloids and their blood clearance and organ distribution in the rat

    Br J Exp Path

    (1966)
  • FrierM et al.

    The physical and chemical characteristics of sulphur colloids

    Eur J Nucl Med

    (1981)
  • DornfestBS et al.

    Effects of sera of normal, anemic and leukemic rats on particle size distribution of 99mTechnetium-sulfur colloid in vitro

    J Reticuloendothel Soc

    (1977)
  • PerssonRBR et al.

    Technetium-99msulfide colloid preparation for scintigraphy of the reticuloendothelial system

    Acta Radiol Ther Phys Biol

    (1970)
  • ZumWinkel K
  • GriffinFM et al.

    Studies on the mechanism of phagocytosis I. Requirements of circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane

    J Exp Med

    (1975)
  • WarbickA et al.

    An evaluation of radiocolloid sizing techniques

    J Nucl Med

    (1977)
  • MartindaleAA et al.

    Technetium99m-antimony colloid for bone-marrow imaging

    J Nucl Med

    (1980)
  • BillinghurstMW et al.

    Colloidal particle-size determination by gel filtration

    J Nucl Med

    (1979)
  • ReskeSN et al.

    In vivo assessment of phagocytic properties of Kupffer cells

    J Nucl Med

    (1981)
  • PedersenB et al.

    Evaluation of methods for sizing of colloidal radiopharmaceuticals

    Eur J Nucl Med

    (1981)
  • Cited by (180)

    • The worse survival outcomes reported for melanoma patients having sentinel node biopsy after lymphoscintigraphy the previous day do not appear to be due to overnight migration of Tc99m-nanocolloid tracer

      2021, European Journal of Surgical Oncology
      Citation Excerpt :

      Distribution of the radiotracer is affected particularly by particle size and small-particle colloids seem preferable for SNB. However, distribution is also affected by other tracer properties such as shape, surface charge and number of Tc atoms per colloid particle, specific activity, depth and site of injection, as well as lymphatic drainage and availability of macrophages in the lymph node(s) [3]. Most European centres use Tc99m-nanocolloid (mean particle size 5–80 nm), whereas microfiltered Tc99m-sulphur colloid is usually used in the United States (mean particle size 100–220 nm) and Tc99m-labelled antimony trisulphide in Australia (mean particle size 3–30 nm) [4].

    • Lymphatic mapping and sentinel lymphadenectomy for breast cancer

      2018, The Breast: Comprehensive Management of Benign and Malignant Diseases
    • Biodistribution of radiolabeled polyglutamic acid and PEG-polyglutamic acid nanocapsules

      2017, European Journal of Pharmaceutics and Biopharmaceutics
      Citation Excerpt :

      The knowledge accumulated so far has led to the identification of a number of factors, which could potentially influence the access of the nanocarriers to the lymphatic system. These factors include the particle size [4,5] and the surface properties of the nanocarriers [6,7] as well as the administration route [8,9]. For example, several studies have shown that, following subcutaneous administration, small nanocarriers (size close to 100 nm) can be efficiently drained from the interstice of the injection site into the lymphatics and be retained in the lymph nodes [10,11].

    View all citing articles on Scopus
    *

    Supported in part by grants from the John and Augustapersson Foundation for Medical Research, Lund, Åke Wiberg Foundation, Stockholm, and the Swedish Medical Research Council, Project No. B83-17X-06573-01.

    View full text